We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

MacroGenics Initiates Phase I Clinical Trial of MGAH22 for Patients with HER2-expressing Solid Tumors

News   Jan 20, 2011

 
MacroGenics Initiates Phase I Clinical Trial of MGAH22 for Patients with HER2-expressing Solid Tumors
 
 
 

RELATED ARTICLES

Treating Diabetes in Older Adults: Simpler Medication Regimens, Looser Glycemic Targets

News

Simplifying medication regimens and tailoring glycemic targets in older adults with diabetes improves adherence and avoids treatment-related complications, according to a Clinical Practice Guideline issued today by the Endocrine Society.

READ MORE

Drug Designed to Treat Opioid Cravings Begins Clinical Trial Testing

News

Researchers at the University of Maryland School of Medicine (UMSOM) Institute of Human Virology (IHV) are collaborating with scientists at the National Institutes of Health to test an experimental drug to curb opioid cravings.

READ MORE

Plant Immunity Cut to Size

News

Researchers have found a link between a class of enzymes and immune signals that is rapidly triggered upon physical damage in plants.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE